263 results found for 'dental-implant-cost.asia'.
FIND and Unitaid invest US$ 50 million to speed lifesaving testing and treatment solutions to the COVID-19 pandemic’s frontlines
News | 09 November 2021
...Southeast Asia, Latin America, and the Western Pacific, where testing capacity is insufficient and life-saving treatments are practically unavailable. The grants will generate high-quality evidence to inform the World Health...
Unitaid commits US$ 56 million to boost access to medical oxygen globally, calls on other donors to close US$ 1 billion gap
News | 17 March 2022
...lower costs, strengthen infrastructure, expand technical capacity, and ensure the safe use of medical oxygen Oxygen remains a critical component of the global COVID-19 response – 75% of patients hospitalized...
COVID-19 creates new urgency for access to HIV self-testing, says global health agency Unitaid
News | 30 November 2021
...other region. In contrast, significant gaps remain in Asia and Latin America, where just 10% and 6% of countries are implementing HIV self-testing respectively. HIV self-testing has helped reach populations...
Landmark deal secures significant discount on price of medicine to prevent TB
News | 31 October 2019
...Jon Fairest, Vice President, External Affairs Africa and Eurasia Middle East. “We believe that this sustainable commercial approach will widen access to the new standard of care for latent tuberculosis...
Johnson & Johnson pricing agreement for critical TB drug still unfairly restricts access in countries where the need is greatest
News | 29 September 2023
...deal is an incomplete solution that will restrict access to lower cost medicines in the near future. Upcoming competition from multiple generic manufacturers is expected to lead to lower prices,...
R17-2020-e Costed Extension of the Self-Testing AfRica (STAR) Initiative
Publication
R12-2020-e Cost Extension for the Project ‘Accelerating Patient Access to Optimal Antiretrovirals and Relevant Health Products’
Publication
World Hepatitis Day: Why Unitaid is investing in hepatitis C
News | 28 July 2014
...US Food and Drug Administration (FDA) approved the first pill that may not require weekly interferon injections. At the end of 2013, this medicine cost $84,000 for a 12-week course....
Unitaid invests in better, safer and simpler treatments and preventive therapy for multidrug-resistant TB in children
News | 07 October 2019
...on optimal dosing, safety, efficacy, acceptability and costs of these MDR-TB medications for kids, an important step in creating policies for their use shaping the market for these better formulations...